Smart Share Global Limited (EM)
USD 0.76
(-1.22%)
USD 0.76
(-1.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 416.49 Million | 708.14 Million | 226.77 Million | 536.11 Million | 444.04 Million |
| Net Income | 87.74 Million | -711.24 Million | -124.61 Million | 75.42 Million | 166.6 Million |
| Depreciation & Amortization | 275.3 Million | 449.06 Million | 396.9 Million | 343.38 Million | 194.15 Million |
| Deferred income taxes | 12.18 Million | -65.43 Million | 554 Thousand | 17.66 Million | 16.23 Million |
| Stock-based compensation | 20.33 Million | 28.24 Million | 30.67 Million | 29.75 Million | 39.08 Million |
| Change in working capital | -163.14 Million | 415.77 Million | -715.31 Million | -177.24 Million | -64.35 Million |
| Other non-cash items | 174.83 Million | 591.73 Million | 638.57 Million | 247.14 Million | 92.32 Million |
| Investing Cash Flow | -598.53 Million | -1.02 Billion | -1.71 Billion | -261.48 Million | -868.29 Million |
| Investments in PPE | -182.01 Million | -442.87 Million | -472.39 Million | -416.91 Million | -580.2 Million |
| Acquisitions | - | - | 283.12 Million | -155.43 Million | 288.08 Million |
| Investment purchases | -7.27 Billion | -7.68 Billion | -2.22 Billion | -304.8 Million | -567.8 Million |
| Sales/Maturities of investments | 6.85 Billion | 7.1 Billion | 982 Million | 460.23 Million | 279.71 Million |
| Other Investing Activities | 7.31 Million | 3.71 Million | -283.12 Million | 155.43 Million | -288.08 Million |
| Financing Cash Flow | -27.95 Million | -78.45 Million | 1.56 Billion | 654.57 Million | 579.66 Million |
| Debt repayment | - | - | -24.5 Million | -394.6 Million | -57.51 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -13.7 Million | -19.73 Million | -10.6 Million | - | -105.13 Million |
| Common Stock Issuance | - | - | 896.32 Million | - | - |
| Other Financing Activities | -14.25 Million | -58.71 Million | 1.49 Billion | 1.04 Billion | 742.32 Million |
| Accounts receivables | -260.11 Million | 586 Thousand | -4.96 Million | 178 Thousand | -20.12 Million |
| Accounts payables | -23.25 Million | 149.25 Million | -45.38 Million | 117.96 Million | 117.36 Million |
| Inventory | 306.83 Million | -5.95 Million | -4.37 Million | - | - |
| Other working capital | -186.61 Million | 271.88 Million | -660.59 Million | -295.38 Million | -161.6 Million |
| Cash at beginning of period | 984.38 Million | 1.33 Billion | 1.3 Billion | 380.53 Million | 229.48 Million |
| Cash at end of period | 781.89 Million | 984.38 Million | 1.33 Billion | 1.3 Billion | 380.53 Million |
| Capital Expenditure | -182.01 Million | -442.87 Million | -472.39 Million | -416.91 Million | -580.2 Million |
| Effect of forex changes on cash | 7.5 Million | 42.09 Million | -42.79 Million | -6.23 Million | -4.36 Million |
| Net cash flow / Change in cash | -202.49 Million | -352.21 Million | 33.09 Million | 922.96 Million | 151.04 Million |
| Free Cash Flow | 234.48 Million | 265.26 Million | -245.61 Million | 119.2 Million | -136.16 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 87.74 Million | 6.9 Million | 3.49 Million | 1.57 Million | -47.01 Million | -711.24 Million |
| Depreciation & Amortization | 275.3 Million | - | - | - | - | 449.06 Million |
| Deferred income taxes | 12.18 Million | - | - | - | - | -65.43 Million |
| Stock-based compensation | 20.33 Million | - | - | - | - | 28.24 Million |
| Change in working capital | -163.14 Million | - | - | - | - | 415.77 Million |
| Other non-cash items | 174.83 Million | -6.9 Million | -3.49 Million | -1.57 Million | 47.01 Million | 591.73 Million |
| Investing Cash Flow | -598.53 Million | - | - | - | - | -1.02 Billion |
| Investments in PPE | -182.01 Million | - | - | - | - | -442.87 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -7.27 Billion | - | - | - | - | -7.68 Billion |
| Sales/Maturities of investments | 6.85 Billion | - | - | - | - | 7.1 Billion |
| Other Investing Activities | - | - | - | - | - | 3.71 Million |
| Financing Cash Flow | -27.95 Million | - | - | - | - | -78.45 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -13.7 Million | - | - | - | - | -19.73 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14.25 Million | - | - | - | - | -58.71 Million |
| Accounts receivables | - | - | - | - | - | 586 Thousand |
| Accounts payables | -23.25 Million | - | - | - | - | 149.25 Million |
| Inventory | 306.83 Million | - | - | - | - | -5.95 Million |
| Other working capital | - | - | - | - | - | 271.88 Million |
| Cash at beginning of period | 984.38 Million | 68.16 Million | 103.58 Million | 138.58 Million | 85.14 Million | 1.33 Billion |
| Cash at end of period | 781.89 Million | 125.15 Million | 68.16 Million | 103.58 Million | 138.58 Million | 984.38 Million |
| Capital Expenditure | -182.01 Million | - | - | - | - | -442.87 Million |
| Effect of forex changes on cash | 7.5 Million | - | - | - | - | 42.09 Million |
| Net cash flow / Change in cash | -202.49 Million | 56.99 Million | -35.41 Million | -35 Million | 53.43 Million | -352.21 Million |
| Free Cash Flow | 234.48 Million | - | - | - | - | 265.26 Million |
LAVV3
MEDS
600731
112040
9262
TODGF